Last reviewed 2026-04-23 · How we verify

NETILDEX™ eye drops solution

NETILDEX combines netilmicin (an aminoglycoside antibiotic) with dexamethasone (a corticosteroid) to provide antimicrobial and anti-inflammatory effects in the eye.

NETILDEX combines netilmicin (an aminoglycoside antibiotic) with dexamethasone (a corticosteroid) to provide antimicrobial and anti-inflammatory effects in the eye. Used for Bacterial conjunctivitis with inflammation, Bacterial keratitis, Post-operative ocular inflammation and infection prophylaxis.

At a glance

Mechanism of action

Netilmicin inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit, providing broad-spectrum antibacterial coverage. Dexamethasone suppresses local inflammatory responses and immune-mediated tissue damage. Together, they address both infection and inflammation in ocular conditions.

Approved indications

• Bacterial conjunctivitis with inflammation
• Bacterial keratitis
• Post-operative ocular inflammation and infection prophylaxis

Common side effects

• Ocular irritation or discomfort
• Transient blurred vision
• Allergic conjunctivitis
• Increased intraocular pressure (with prolonged use)

Key clinical trials

• Clinical Study to Evaluate the Efficacy and Tolerability of an Anti-inflammatory/Antibiotic Treatment Following Ocular Cataract Extraction (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

• NETILDEX™ eye drops solution CI brief — competitive landscape report
• NETILDEX™ eye drops solution updates RSS · CI watch RSS
• SIFI SpA portfolio CI